Global CGT CDMO Competitive Landscape Professional Research Report 2024

Global CGT CDMO Competitive Landscape Professional Research Report 2024

Research Summary

A CGT CDMO (Contract Development and Manufacturing Organization for Cell and Gene Therapy) is a specialized service provider that supports the biopharmaceutical industry by offering comprehensive development and manufacturing solutions for cell and gene therapies. These organizations facilitate every stage of the therapy development process, from research and development to clinical trial material production, regulatory compliance, and large-scale commercial manufacturing. By leveraging advanced facilities, expert personnel, and regulatory expertise, CGT CDMOs enable biotech and pharmaceutical companies to accelerate the development and commercialization of innovative treatments. This allows companies to focus on their core competencies while ensuring efficient, high-quality production and adherence to regulatory standards, ultimately speeding up the delivery of advanced therapies to patients.

According to DIResearch's in-depth investigation and research, the global CGT CDMO market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of CGT CDMO include WuXi AppTec, OBiO, GenScript, Porton, Lonza, Pharmaron, Catalent, Thermo Fisher, Oxford Biomedica (OXB), Asymchem, Rentschler Biopharma, Novartis etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of CGT CDMO. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global CGT CDMO market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the CGT CDMO market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of CGT CDMO industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of CGT CDMO Include:

WuXi AppTec

OBiO

GenScript

Porton

Lonza

Pharmaron

Catalent

Thermo Fisher

Oxford Biomedica (OXB)

Asymchem

Rentschler Biopharma

Novartis

CGT CDMO Product Segment Include:

Immune Cells

Stem Cells

Viral Vectors

Plasmid DNA

CGT CDMO Product Application Include:

Pharmaceutical and Biotechnology Companies

Research and Academic Institutions

Hospital

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global CGT CDMO Industry PESTEL Analysis

Chapter 3: Global CGT CDMO Industry Porter’s Five Forces Analysis

Chapter 4: Global CGT CDMO Major Regional Market Size and Forecast Analysis

Chapter 5: Global CGT CDMO Market Size and Forecast by Type and Application Analysis

Chapter 6: North America CGT CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe CGT CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China CGT CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) CGT CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America CGT CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa CGT CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global CGT CDMO Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources